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Abstract
Background: Concomitant with the rise in the popularity of DNA microarrays has been a surge of proposed methods 
for the analysis of microarray data. Fully controlled "spike-in" datasets are an invaluable but rare tool for assessing the 
performance of various methods.
Results: We generated a new wholly defined Affymetrix spike-in dataset consisting of 18 microarrays. Over 5700 RNAs 
are spiked in at relative concentrations ranging from 1- to 4-fold, and the arrays from each condition are balanced with 
respect to both total RNA amount and degree of positive versus negative fold change. We use this new "Platinum 
Spike" dataset to evaluate microarray analysis routes and contrast the results to those achieved using our earlier 
Golden Spike dataset.
Conclusions: We present updated best-route methods for Affymetrix GeneChip analysis and demonstrate that the 
degree of "imbalance" in gene expression has a significant effect on the performance of these methods.
Background
As a result of their ability to detect the expression levels
of tens of thousands of genes simultaneously, DNA
microarrays have quickly become a leading tool in diverse
areas of biological and biomedical research. Given this
popularity and the associated accumulation of numerous
microarray analysis methods, there is a critical need to
know the accuracy of microarray technology and the best
ways of analyzing microarray data. Important advances
toward this goal were made by the MicroArray Quality
Control (MAQC) project launched by US Food and Drug
Administration [1]. For the MAQC study, two distinct
reference RNA samples were mixed together at specified
ratios and then hybridized to different microarray plat-
forms at multiple test sites. This design enabled the
MAQC consortium to evaluate the reproducibility of
microarray technology and the consistency between plat-
forms. The study demonstrated that high levels of both
intraplatform and interplatform concordance can be
achieved in detecting differentially expressed genes
(DEGs) when the microarray experiment is performed
appropriately. However, as the exact identities of the indi-
vidual RNAs in the reference samples were unknown, the
MAQC project was not able to address questions regard-
ing the overall accuracy of microarray technology and
analysis methods.
Spike-in experiments are designed to address questions
about the correctness of microarray data and have been
used extensively to compare among different analysis
methods. Currently there are four major spike-in datasets
available for the Affymetrix microarray platform: the
Affymetrix spike-in dataset for cross platform compari-
sons [2], the Affymetrix Latin square dataset [3], the
Gene Logic spike-in dataset [4] and the Golden Spike
dataset [5]. Different from the other spike-in studies
where a small number of spike-in RNAs were mixed with
large unknown background RNA samples, the Golden
Spike dataset contains a defined background sample of
over 2500 RNAs and over 1300 spike-in RNAs that differ
by known relative abundance with fold changes from 1.2
to 4. This dataset was used to determine the preferred
choices at each step in microarray analysis to achieve
optimal DEG detection [5], and subsequent work by a
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variety of researchers has extended these findings and
proposed improved analysis alternatives [6-11].
Although it has enjoyed wide-spread use in the bioin-
formatics community, concerns have been raised over
two aspects of the Golden Spike dataset: differentially
expressed RNAs are more abundant in the spike arrays
than in the control arrays [12], and the experiment con-
sists of only a limited (triplicate) set of technical repli-
cates [13]. The former condition violates a main
assumption of most microarray normalization methods,
which presuppose that up-and down-regulation of genes
is balanced and total RNA amount is equivalent in both
samples. In order to address both of these concerns as
well as to explore further questions regarding ways of
analyzing microarray data, we have constructed a new
wholly-defined Affymetrix GeneChip control dataset, the
"Platinum Spike" dataset. This new dataset consists of a
total of 18 microarrays with evenly balanced up and down
gene expression between conditions. We used the Plati-
num Spike dataset to compare over 40,000 possible analy-
sis routes derived from combining different methods in
individual steps of the analysis procedure in order to
determine the optimal path for DEG detection and to
pinpoint the most critical steps affecting analysis accu-
racy. We find that how normalization is conducted has a
dramatic effect on performance and depends on the bal-
ance of gene expression between the sets of arrays being
compared. The highly balanced Platinum Spike dataset,
and comparisons between it and the unbalanced Golden
Spike dataset, provide a valuable resource for developing
and testing analysis procedures to handle a range of dis-
tributions of DEGs in Affymetrix GeneChip experiments.
The Platinum Spike raw data are available at http://www.
ccr.buffalo.edu/halfon/spike/index.html, and through
NCBI's Gene Expression Omnibus (GEO; accession
GSE21344) [14].
Results and Discussion
Experimental design
The Platinum Spike dataset consists of 18 Affymetrix
Drosophila Genome 2.0 microarrays representing two
different "conditions" ("A" and "B", nine arrays each), each
of which contains the identical 5749 cRNAs, but at differ-
ent defined relative concentrations. We generated three
independently labeled samples for each condition, and
hybridized each sample to three arrays. Therefore the
nine arrays for each condition consist of three sample
replicate groups, and each group contains three technical
replicates (Figure 1). For each condition, the total amount
of cRNA is the same, and there are similar numbers of
up-and down-regulated cRNAs: 1146 and 947 individual
RNAs are up-and down-regulated in condition A versus
condition B respectively, with known fold changes vary-
ing between 1.2 and 4 fold, and 3643 RNAs are identical
in abundance between the two conditions (Table 1; Addi-
tional file 1, Figure S1). Our previous Golden Spike data-
set [5] was criticized for having higher-than-typical
hybridization signal intensities [12]. We calibrated the
amount of RNA hybridized to the arrays in the current
experiment so that gene intensities fell within the range
commonly seen in experiments stored in GEO (data not
shown). 24 additional RNAs were spiked in at defined
(absolute) concentrations to provide further validation
that our RNA concentrations fell within a reasonable
range (~1 pM to 100 pM, approximating a few copies to a
few hundred copies of transcript per cell [15]). The Plati-
num Spike dataset therefore differs from the earlier
Golden Spike dataset in four critical ways: it includes
1889 additional individual RNAs (an increase of close to
50%) ;  it  is  ba la nc ed wit h r es pect t o t ota l la be led RNA
amount and extent of up-and down-regulation for each
experimental condition; the observed probe intensities
Figure 1 Design and structure of the Platinum Spike experiment. 
(A) Design of the Platinum Spike experiment. PCR products were col-
lected into 28 distinct pools, and three independent in vitro transcrip-
tion and labeling reactions were performed for each pool. Labeled 
cRNAs from each individual pool were then added at specified 
amounts to samples A and B to achieve the desired fold change differ-
ences between samples. Note that this method ensures that the rela-
tive concentrations of cRNAs from the same pool are always identical. 
Each sample was hybridized to three arrays (see Methods). (B) Struc-
ture of the 18 Platinum Spike arrays showing the three ways of normal-
ization (normalization groups) used in the analysis. The technical 
normalization group normalizes each set of technical replicates for a 
total of six normalizations. The conditional normalization group uses all 
of the arrays from the same condition, a total of two normalizations. 
The all normalization group consists of a single normalization using all 
of the arrays in the experiment.
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Table 1: Number of DGCr1 clones and assigned fold change for each PCR pool.
pool
name
Number of
clones
Number of assigned
probe sets*
Relative amount
in A
Relative amount
in B
Designated fold
change (A vs B)
1 170 161 1 1.2 0.83
21 9 2 1 9 6 2 1 2 . 0 0
31 9 2 1 8 1 1 . 5 1 1 . 5 0
4 192 177 1 2.5 0.40
51 8 7 1 7 6 1 1 1 . 0 0
61 1 6 1 0 4 3 1 3 . 0 0
71 9 2 2 0 2 3 . 5 1 3 . 5 0
8 192 204 1 1.5 0.67
91 9 2 2 0 4 1 4 0 . 2 5
10 192 192 1.7 1 1.70
11a 192 200 1 1 1.00
12a 121 123 1 1 1.00
13a 192 195 1 1 1.00
14a 192 197 1 1 1.00
15a 192 203 1 1 1.00
16a 191 191 1 1 1.00
17a 139 141 1 1 1.00
18a 192 193 1 1 1.00
19a 192 186 1 3.5 0.29
11b 191 197 1 1 1.00
12b 223 225 1 1 1.00
13b 237 246 1 1 1.00
14b 288 302 1 1 1.00Zhu et al. BMC Bioinformatics 2010, 11:285
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are more in line with what is typically seen in an Affyme-
trix experiment; and it consists of both technical and
sample replicates.
Assessment of present/absent calls
The Affymetrix Drosophila Genome 2.0 arrays measure
the levels of over 18,500 transcripts using probe sets com-
posed of 14 oligonucleotide probe pairs per transcript.
Each probe pair contains two 25 bp DNA oligonucleotide
probes: the perfect match (PM) probe, which is exactly
complementary to the target cRNA, and the mismatch
(MM) probe, which is almost identical to the PM probe
except that the central nucleotide has been changed to
the complementary base. Affymetrix estimates whether
or not the cRNA target of a probe set is present in a sam-
ple based on the MAS 5.0 detection algorithm [16], as fol-
lows: to obtain the present/absent call for each probe set
in an array, a discrimination score (PM-MM)/(PM+MM)
is calculated for every PM, MM probe pair, and then a
Wilcoxon signed rank test is performed to test whether
the median of the score values is greater than a pre-speci-
fied value τ (which we set equal to zero; see Methods). As
we knew in advance what cRNAs were in fact present or
absent in the Platinum Spike dataset, we could evaluate
the performance of the detection algorithm by using
Receiver Operating Characteristics (ROC) curves.
As background correction and probe normalization
could change the probe intensities and therefore affect
the results of the detection algorithm, we evaluated the
performance of the present/absent call for multiple analy-
sis routes obtained from different combinations of popu-
lar methods for these two steps (Figure 2, see Methods).
Eight different ways of background correction were used,
including no background correction, rma [17], MAS 5.0
(mas) [16], and five different scenarios of gcrma  [18].
Probe normalization was either not performed, or per-
formed using one of the six normalization methods cou-
pled with one of three "normalization groups." The arrays
in the Platinum Spike experiment fall into two distinct
conditions. Each condition contains three sample repli-
cate groups, and each sample group contains three tech-
nical replicates. At the normalization step, therefore, we
could normalize among technical replicates and perform
six normalizations ("technical" normalization group),
normalize among arrays under the same condition and
perform two normalizations ("conditional" group), or
normalize once using all arrays ("all" group) (Figure 1B).
The latter, in which all arrays are used for normalization,
is the typical choice in microarray analysis and is based
on a popular assumption that there is an equal amount of
up-and down-regulation in the samples leading to com-
parable intensity distributions from all arrays. However,
w e  a n d  o t h e r s  h a v e  a r g u e d  t h a t  t h i s  a s s u m p t i o n  m a y
often not be justified [19-21].
In the Platinum Spike dataset, there are 13,337 empty
probe sets and 5615 probe sets whose cRNA targets are
present in the samples (including the 18 probe sets
designed for Affymetrix Eukaryotic Hybridization Con-
trols and 24 probe sets hybridized to the cRNAs spiked in
15b 288 303 1 1 1.00
16b 288 292 1 1 1.00
17b 288 300 1 1 1.00
18b 250 243 1 1 1.00
19b 265 274 3.5 1 3.50
*There are 202, 15 and 1 probe sets assigned to clones present in two, three and four different pools respectively.
Table 1: Number of DGCr1 clones and assigned fold change for each PCR pool. (Continued)
Figure 2 Methods used to generate present/absent calls. Each of 
the six different normalization methods can be coupled with each of 
the three normalization groups. A total of 152 routes are created by 
combining the various options.Zhu et al. BMC Bioinformatics 2010, 11:285
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with known concentration). The relative performance of
all routes from different combinations of background
correction and probe normalization was assessed based
on a summary statistic of the ROC curve, rAUC0.05. This
statistic measures the Area Under the Curve (AUC) rela-
tive to the maximum AUC value (0.05) when the false
positive rate (1-specificity) is less than or equal to 0.05.
That is,   where pAUC0.05 is
the partial AUC [22] when the false positive rate (FPR) ≤
0.05. We define FPR as the number of probe sets that are
incorrectly called "present" divided by the number of
probe sets whose targets are truly absent, while true posi-
tive rate (TPR) is the number of probe sets that are cor-
rectly called "present" divided by the number of probe
sets whose targets are truly present in the samples. We
used a conservative FPR cutoff (0.05), as researchers are
typically interested in performance when the number of
false positives is relatively small. A larger rAUC0.05 value
corresponds to a higher true positive rate and lower false
positive rate, and therefore better performance. As the
MAS 5.0 detection algorithm is applied on each individ-
ual array, we obtained 18 rAUC0.05 values corresponding
to the 18 arrays and used the average value ( )
for evaluation.
A total of 152 different routes were compared, and
most routes generated reasonably high 
(median   = 0.808, median   (average
TPR across 18 arrays when actual FPR ≤ 0.05) = 0.835,
Figure 3A). At a false positive rate not greater than 5%,
the best route on average calls "present" approximately
85% of probe sets whose cRNA targets are truly present.
gcrma background correction using maximum likelihood
estimation (gcrma-lml and gcrma-rml) generally outper-
formed other background correction methods by a small
margin, although it could also lead to very poor results
when used with the wrong combination of other steps
(Figure 3B). Different normalization methods mostly per-
formed similarly to no probe normalization. The excep-
tion to this is invariantset normalization, which showed
larger variation than the others, and whose best perfor-
mance was substantially worse than the best performance
of any other normalization method (Figure 3C). Choice of
normalization group also had little effect on overall per-
formance (Figure 3D). The limited contribution of probe
normalization might be due to the fact that the detection
algorithm is designed to be applied on an individual chip
basis.
Detection of differentially expressed genes
One of the primary uses for microarrays is to detect the
genes whose expression levels have changed between
compared conditions. DEG detection using Affymetrix
data requires a series of analysis steps including back-
ground correction, probe normalization, PM correction,
probe summarization, probe set normalization and DEG
testing (Figure 4, see Methods). For each of these steps,
we picked several representative methods based on dif-
ferent algorithms, and assessed all possible combinations
of these methods. We also tested several methods which
themselves already combine multiple steps. In total, we
examined 41,423 different routes and evaluated the per-
formance of each combination using rAUC0.05.
Most of the routes performed well on the Platinum
Spike dataset (median rAUC0.05 = 0.696, median TPR0.05 =
0.720; Additional file 1, Figure S3A), with the best 1% of
routes all yielding a TPR0.05 > 0.858. (Here TPR is the
number of probe sets that are correctly predicted to be
DEGs divided by the number of probe sets whose targets
are truly DEGs, while FPR is the number of probe sets
that are incorrectly predicted as DEGs divided by the
number of probe sets whose targets are not DEGs). The
Alchemy and GoldenSpike methods, which previously had
been shown to fall among the top methods for the Golden
Spike dataset [5,8], perform strongly on the Platinum
Spike dataset as well, with Alchemy falling within the top
ten (Table 2 and Additional file 1, Figure S3A).
Somewhat surprisingly, we found that the choice of
method at most steps in the analysis had relatively little
impact on overall performance. For instance, while the
overall best route used the gcrma-reb background correc-
tion method, and while the gcrma-rml  and  gcrma-lml
background correction methods were significantly more
enriched in the top 1% of routes (Bonferroni corrected
one sided Fisher exact P-value = 1.031e-07 and 0.030
respectively), the effect was only marginal (odds ratio =
2.134 and 1.561; Figure 5A and Additional file 1, Figure
S4A). Similarly, although invariantset normalization was
found to be highly enriched in the routes of the top 1%
(Bonferroni corrected one sided Fisher exact P-value =
2.455e-35 and odds ratio = 3.905; Figure 5B and Addi-
tional file 1, Figure S4B), the top two routes used scaling
and vsn normalization, respectively. Probe set normaliza-
tion was also found to be of minimal utility, consistent
with the suggestion by Choe et al. [5] that this step is of
importance mainly when the log fold changes are not
c e n t e r e d  a r o u n d  z e r o  a s  a  r e s u l t  o f  u n e q u a l  c R N A
amounts between conditions, which is not the case in the
Platinum Spike dataset (data not shown). Choice of statis-
tical test for DEG detection also had little bearing on per-
formance. Interestingly, the simple fold change method
performed extremely well and was in fact marginally
enriched in the top 1% of routes (Bonferroni corrected
one sided Fisher exact P-value = 4.023e-08 and odds ratio
= 1.884; Figure 5H and Additional file 1, Figure S4H). We
r
p AUC
AUC
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00 5
00 5 .
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treated technical replicates and sample replicates as part
of a single 18-array experiment in order to take advantage
of the resulting larger sample size. Although such a
choice in theory could lead to underestimation of the
overall variance, we consider any such effect to be negligi-
ble in this case as the variation introduced by indepen-
dent sample preparation can be seen to be much smaller
than other sources of variation (Supplemental methods in
Additional file 2, and Additional file 1, Figure S7). The
relatively large number of replicates and overall low vari-
ance in the Platinum Spike dataset may be at least par-
tially responsible for this surprisingly strong performance
achieved by simply ranking probe sets by their fold
change levels.
The most important factors affecting DEG detection
appear to be the probe normalization group, PM correc-
tion method, and summarization method, as the options
selected at these steps had the largest impact on perfor-
mance. Probe normalization among all arrays ("all"
group) was always more likely to produce large rAUC0.05
Figure 3 Performance of present/absent call algorithms on the Platinum Spike dataset. (A) The distribution of the relative AUC values of all test-
ed routes for present/absent call analysis. (B-D) Boxplots of the relative AUC values for each category of methods for background correction (B), probe 
normalization (C), and probe normalization group (D). The blue dashed line in each plot represents the highest observed relative AUC from all con-
sidered routes. "None" indicates routes in which the featured method was not performed.
A B
CD
gZhu et al. BMC Bioinformatics 2010, 11:285
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values than using either the other normalization groups
or no probe normalization at all (Figure 5C and Addi-
tional file 1, Figure S4C; odds ratio for enrichment in top
1% of routes = 3.118, Bonferroni corrected one sided
Fisher exact P-value = 1.336e-28). We speculate that the
improved performance seen when using all arrays might
merely be the result of increased sample size for normal-
ization; performance decreases in proportion with the
number of arrays normalized such that all (18) >condi-
tional (9) >technical (3) ≈ none. pmonly and medianpolish
were consistently the best methods in the PM correction
and summarization steps, respectively. Not only did the
best route use these two methods, but routes using these
two methods always yielded a higher percentage of large
rAUC0.05 values (Figure 5D-F and Additional file 1, Figure
S4D-F). The superiority of pmonly over mas PM correc-
tion is consistent with results reported by [4] but in con-
tradiction to those of [5], likely reflecting differences in
the nature of the various datasets being analyzed (see
below).
In order to test whether the performance of DEG detec-
tion depends on the magnitude of the fold change
between conditions, we calculated rAUC0.05 values for all
routes at each fold change level. The cRNAs spiked in at
each individual fold change level were considered to be
true DEGs, while the fold change = 1 and empty probe
sets were considered as non-DEGs. Consistent with pre-
vious findings using the Golden Spike dataset [5], DEGs
with fold changes below 1.7× were poorly detected by
most of the routes (Additional file 1, Figure S5). Although
the best route for detecting high fold-change DEGs did
not work well for identifying small fold-change DEGs, the
overall best route performed equally well at all fold
change levels, with detection of small fold-change DEGs
only slightly worse than observed for higher fold changes.
Comparison with the Golden Spike dataset
We [5] and others [8,9,11] have used the previously devel-
oped Golden Spike dataset [5] to determine optimal
methods for microarray analysis. Interestingly, however,
many of the methods that were shown to perform
strongly on the Golden Spike dataset did not fall among
the best routes identified here for the Platinum Spike
dataset. One reason for this could be that some methods
did not exist, or were not considered, at the time of those
analyses. On the other hand, the Platinum Spike dataset
and the Golden Spike dataset are two distinct datasets
and might require different analysis strategies. We
addressed this issue in two ways: (1) we analyzed the Plat-
inum Spike dataset using only those methods that had
previously been applied to the Golden Spike dataset, and
(2) we applied all of the methods evaluated here for the
Platinum Spike dataset to the Golden Spike dataset.
Using only those methods that had previously been
applied to the Golden Spike dataset in the Choe et al.
study [5], we found that optimal methods for the Plati-
num Spike dataset were still different from Choe et al.'s
findings (e.g., rma  outperformed  mas  in the Platinum
Spike dataset, Additional file 1, Figure S6). (When applied
to the Golden Spike dataset, as a control, our current
implementations of this subset of methods confirmed the
Choe et al. findings; data not shown). Thus differences in
the datasets, rather than in available algorithms, appear
to be responsible for the differences between the two
studies.
To further investigate the effect of different datasets on
method performance, we also evaluated the DEG detec-
tion performance of 19,507 routes on the Golden Spike
dataset using the same methods--including those not
available at the time of the Choe et al. study--we assessed
for the Platinum Spike dataset. (Note that since the arrays
under each condition of the Golden Spike dataset are all
technical replicates, normalizing by condition is identical
to normalizing by technical replicate, giving only two
possible normalization groups.) Whereas with the Plati-
num Spike dataset a large number of methods gave rea-
s o n a b l y  g o o d  r e s u l t s ,  m o s t  o f  t h e  r o u t e s  w e  t e s t e d
Figure 4 Methods used at each stage of analysis to identify DEGs. 
"None" indicates that a given step was not performed. Several com-
bined or stand-alone methods were also evaluated, including multi-
mgmos, PerfectMatch, GoldenSpike, Alchemy and default settings of 
GCRMA, RMA, and MAS 5.0 (see Methods). Methods that clearly outper-
formed other methods in the Platinum Spike dataset are circled in red. 
The same methods were also applied to the Golden Spike dataset, 
where the technical and conditional normalization groups are identical. 
Methods that clearly outperform other methods in the corresponding 
steps are circled in blue.Z
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Table 2: Top ten routes for the Platinum Spike dataset.
Rank Background 
correction
Probe 
normalization 
methods
Probe 
normalization 
groups
PM 
correction
Summarization Probe set 
normalization 
methods
Probe set 
normalization 
groups
DEG tests rAUC0.05 TPR0.05 TP0.05*
1 gcrma-reb scaling all pmonly medianpolish vsn technical CyberT 0.848 0.880 1710
2 none vsn all pmonly medianpolish constant all SAMR 0.847 0.883 1717
3 gcrma-reb scaling all pmonly medianpolish vsn technical SAMR 0.847 0.877 1705
4 gcrma-reb constant all pmonly medianpolish vsn technical CyberT 0.846 0.879 1709
5 gcrma-reb scaling all pmonly medianpolish vsn technical LIMMA 0.846 0.878 1707
6 gcrma-reb constant all pmonly medianpolish vsn technical LIMMA 0.845 0.878 1706
7 Alchemy 0.845 0.877 1705
8 none vsn all pmonly medianpolish constant all LIMMA 0.845 0.883 1716
9 none vsn all pmonly medianpolish quantiles technical Fold Change 0.844 0.877 1704
10 rma vsn technical pmonly medianpolish scaling all SAMR 0.844 0.878 1707
*the number of correctly detected DEGs at false positive rate cutoff 0.05.Zhu et al. BMC Bioinformatics 2010, 11:285
http://www.biomedcentral.com/1471-2105/11/285
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performed poorly on the Golden Spike dataset (Addi-
tional file 1, Figure S3B). W e did identify a number of
strongly-performing routes, including ones that signifi-
cantly outperformed Alchemy  and  GoldenSpike, which
were reported to be the best methods in previous studies
[5,8]. Importantly, however, we found that these routes do
not correspond to the most strongly performing routes
identified using the Platinum Spike dataset. gcrma-lml
and gcrma-rml were superior to other background cor-
rection methods, and the constant normalization method
was slightly better than others for probe normalization
step. In stark contradiction to the better performance
observed when normalizing using all arrays in the Plati-
num Spike dataset, we found normalization among all
arrays to be deleterious in the Golden Spike dataset for
both probe normalization and probe set normalization,
with clearly improved performance seen with either tech-
nical/conditional group normalization or no normaliza-
Figure 5 Empirical cumulative distribution plots of the relative AUC values for DEG detection using the Platinum Spike dataset. The routes 
are separated based on background correction methods (A), probe normalization methods (B), probe normalization groups (C), PM correction meth-
ods (D), summarization methods (E), probe set normalization methods (F), probe set normalization groups (G), and methods of DEG testing (H). Vertical 
grey dashed lines correspond to the 100th, 99th and 95th percentile of all relative AUC values.
C A B
E F
G H
DZhu et al. BMC Bioinformatics 2010, 11:285
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tion at all (Figure 6). We additionally saw that CyberT is
the optimal DEG test method for the Golden Spike data-
set, consistent with [5].
Although the optimal analysis routes identified for each
dataset are clearly different, we were able to identify
routes that gave acceptable performance on both datasets
as long as the appropriate normalization groups were
used (using all, rAUC0.05 in the Platinum Spike dataset =
0.768 corresponding to 76.86th percentile and using tech-
nical/conditional, rAUC0.05 in the Golden Spike dataset =
0.856 corresponding to 99.99th percentile; brown lines in
Additional file 1, Figure S3). This suggests that the pre-
dominant factor affecting analysis of the two datasets is
how the arrays are grouped for normalization. The oppo-
site performance of the normalization groups between
the Platinum Spike and Golden Spike experiments can be
seen to result from the respective designs of the two data-
sets. The degree of up-and down-regulation in the Plati-
num Spike dataset is balanced, and a similar amount of
labeled cRNA was hybridized to each array. Therefore the
signal intensity across all 18 arrays is similar, even for
arrays from different conditions, and normalization using
all arrays is beneficial (probably due to the increased sam-
ple size). On the contrary, the Golden Spike dataset is
imbalanced and more labeled cRNA was added to the
spike arrays than the control arrays, leading to higher rel-
ative signal intensities in the former. When all arrays are
used for normalization, the true intensity difference
between the two conditions is improperly diminished,
leading to degraded performance. When only arrays from
the same condition are used for normalization, the true
intensity difference between the spike and control arrays
is maintained. The difference in balance between condi-
tions in the two datasets likely contributes to the other
differences we observed in optimal analysis methods as
well, including choice of background correction, PM cor-
rection, summarization and DEG testing. These steps
may be affected by the differences in background hybrid-
ization intensity for the empty probes and the amount of
cross-hybridization caused by the presence of more
labeled cRNA in the spike versus control arrays.
False discovery rate
A common practice in microarray analysis is to estimate
the false discovery rate (FDR), the expected proportion of
false positive results among the detected DEGs, typically
expressed as a q-value for each gene [23]. A number of
methods have been proposed to estimate this statistic in
which the actual q-value is mathematically guaranteed to
be below the estimated q-value. Although statistically
sound, it is unknown how well these q-value estimations
perform in real-world microarray experiments. We have
shown previously for the Golden Spike dataset that the q-
values appear to underestimate the true FDR [5]. Taking
advantage of the full knowledge of the cRNA identities in
the Platinum Spike dataset, we compared the actual FDR
and the estimated q-values by using the results from the
overall top ten DEG detection routes (Figure 7). The esti-
mated q-values were calculated either by permutation or
by the Benjamini and Hochberg method [24] (see Meth-
ods). Our results show that when using the Benjamini
and Hochberg method, the predicted q-values (which can
only be applied to the five of the top ten routes that report
p-values) understate the true FDR in four out of the five
evaluated routes for q = 0.05 (right panel of Figure 7A).
The permutation-based method worked slightly better, as
the true FDR was successfully controlled in six of the ten
routes (left panel of Figure 7A). Nevertheless, these
results show that care must be taken in assessing the FDR
in microarray experiments, as the true FDR is frequently
not successfully controlled.
Control of the FDR requires that the p-values from sta-
tistical evaluation of the genes not differentially
expressed ("null genes") be uniformly distributed in the
interval (0,1). Dabney and Storey [13] show that this is
not the case for the Golden Spike data and suggest that
non-uniform null p-value distribution is the cause for the
underestimation of the FDR for those data observed in
[5]. They also claim that the non-uniform p-values are
due to specific design flaws in the Golden Spike experi-
ment, a claim we have disputed [25]. Fodor et al. [26] lend
support to our view with their finding that the Affymetrix
Latin Square experiment also shows a non-uniform dis-
tribution of the null gene p-values. The null gene p-values
in the current dataset also fail to form a uniform distribu-
tion (Figure 7B), despite the great care we have taken to
ensure that the Platinum Spike experiment closely
approximates the conditions of a "typical" microarray
experiment. This observation lends further support to
the idea that the skewed distribution is not dataset spe-
cific but rather due to more general factors, perhaps from
the analysis procedures themselves [26].
Sample size study
Due to high costs and/or limited biological samples,
microarray experiments are frequently performed using
three or even fewer replicates. We find that in the Plati-
num Spike dataset, the variation introduced by sample
preparation and hybridization are similarly small (Sup-
plemental methods in Additional file 2, and Additional
file 1, Figure S7), allowing us to treat all of the arrays from
each experimental condition together as a single 9-fold
replicated experiment. By randomly drawing and analyz-
ing differently sized subsets of the nine arrays, we
addressed the question of how many arrays are needed to
identify DEGs with high accuracy and specificity [27-34].
We evaluated the performance of DEG detection when
using as few as two up through seven arrays per condi-Zhu et al. BMC Bioinformatics 2010, 11:285
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tion. In each case, we applied nine analysis routes (the
best ten as determined above, excluding Alchemy, modi-
fied to use only normalization across all arrays) on 200
samples formed by randomly selecting arrays from the
total nine "A" and nine "B" arrays (Table 3, Additional file
3, Table S1 and Additional file 1, Figure S8). For five of the
nine routes being tested, we found that using five arrays
per condition can reach at least 95% of the performance
(assessed by rAUC0.05) seen when all nine arrays are used,
while for two routes four arrays were sufficient (Table 3).
These results suggest that at least five replicate arrays are
required to achieve near-optimal DEG discovery in a
microarray experiment. As the variation among arrays in
"real" experiments is likely to be greater than in the Plati-
num Spike dataset, which lacks potential additional varia-
tion introduced by using different biological samples, an
even larger number of replicates may be necessary. On
the other hand, the magnitude of the change in correctly
identified DEGs when moving from four to five replicates
is relatively small (average 26 ± 24 DEGs, a 1.3% change in
TPR0.05) ,  s u g g e s t i n g  t h a t  f o u r  r e p l i c a t e  a r r a y s  w i l l  f r e -
quently give acceptable results. The commonly-used
Figure 6 Empirical cumulative distribution plots of the relative AUC values for DEG detection using the Golden Spike dataset, displayed as 
in Figure 5.
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three replicates, while clearly sub-optimal in absolute
terms, also tends to give reasonable results with an aver-
age change in DEGs of 73 ± 34 (a 3.8% change in TPR0.05)
when compared to using four arrays (Additional file 3,
Table S1).
Conclusions
The wholly-controlled Platinum Spike dataset provides
an important addition to the available spike-in control
datasets available for assessing Affymetrix microarray
analysis methods. Our analysis of over 40,000 analysis
routes on this dataset reveals that in general the state of
Affymetrix analysis is in good shape: most commonly
used methods perform strongly. The best performance
when using default settings for MAS 5.0, RMA, and
GCRMA yielded between 84%-87% sensitivity at a 5%
false positive rate, close to that achieved by the best over-
all routes. Choice of probe normalization group, PM cor-
rection method, and summarization method were the key
factors affecting outcome. Our sample size study suggests
that while five or more replicates is the preferred choice,
Figure 7 Accuracy of false discovery rate estimation on the Platinum Spike dataset. (A) The accuracy of the predicted FDR of the top 10 routes 
based on 1500 permutations (left), or the method of Benjamini and Hochberg (right). The predicted FDRs for the latter are only available for routes 
that report p-values. (B) The p-value distribution of null probe sets for the routes ranked as the first (left) and eighth (right) respectively to present two 
distinct distribution patterns observed for five of the top 10 routes whose p-values are available. "Null" probe sets includes both probe sets present 
with fold change = 1 and empty probe sets. Inset shows the p-value distribution of present probe sets with fold change = 1 only.
A
B
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four or even three replicates, typical sizes for microarray
studies, produce reasonable outcomes.
At the same time, our data reveal several areas that
remain in need of further development. As noted previ-
ously [5,26], methods for assessing the false discovery
rate tend to underestimate its size, providing a false sense
of confidence about the specificity of the results, even in
the highly controlled, idealized Platinum Spike dataset. A
proposed solution to this problem [26] did not appear to
be effective with the Platinum Spike dataset (data not
shown), suggesting that continued investigation of this
important issue is warranted. Perhaps more critically, our
current data suggest that accuracy in microarray analysis
is significantly affected by the nature of the transcrip-
tomes being compared in an experiment. In this respect,
the Platinum Spike dataset serves as a useful complement
to our previous Golden Spike dataset. Together, they rep-
resent extremes of highly balanced (Platinum Spike) and
imbalanced (Golden Spike) changes of gene expression
between the compared experimental conditions and illus-
trate the importance of designing and choosing analysis
algorithms appropriate for the underlying RNA distribu-
tions in a microarray experiment. Methods that work well
on the Platinum Spike dataset perform far less well on the
Golden Spike dataset, which is much more sensitive to
choice of analysis route. Although analysis routes that
give acceptable performance on both datasets can be
identified, they are suboptimal and moreover still depend
on appropriate choice of normalization group for each
dataset. In the Golden Spike dataset, which has a consid-
erable degree of imbalanced gene expression between the
two compared conditions, using the "conditional" nor-
malization group gives superior performance. However,
normalizing in this manner carries the obvious risk that
differences introduced by significant technical variation
between the conditions--experimental artifact--will be
artificially exaggerated rather than eliminated by normal-
ization. The problem lies in the fact that with real experi-
mental data, one cannot know which is more severe,
technical variation between the conditions or the degree
of "imbalance" in the true RNA distributions. Therefore,
means to properly assess underlying RNA imbalances
and other dataset-specific issues, and methods to allow
for proper normalization among arrays that can account
both for imbalance and for technical artifact, are urgently
needed in order to guide researchers to the most effective
Table 3: One-sided p-values of the Wilcoxon singed rank test for sample size studya.
Routesb The number of arrays
2345 6 7
gcrma-reb.scaling.all.pmonly.medianpolish.vsn.all.CyberT 3.44e-47c 5.08e-12 ns ns ns ns
none.vsn.all.pmonly.medianpolish.constant.all.SAMR 8.53e-59 1.30e-42 1.43e-06 ns ns ns
gcrma-reb.scaling.all.pmonly.medianpolish.vsn.all.SAMR 6.22e-61 4.04e-49 1.59e-12 ns ns ns
gcrma-reb.constant.all.pmonly.medianpolish.vsn.all.CyberT 2.15e-52 9.56e-20 ns ns ns ns
gcrma-reb.scaling.all.pmonly.medianpolish.vsn.all.LIMMA 6.22e-61 3.58e-56 2.04e-26 ns ns ns
gcrma-reb.constant.all.pmonly.medianpolish.vsn.all.LIMMA 6.22e-61 4.36e-59 7.32e-36 5.56e-13 ns ns
none.vsn.all.pmonly.medianpolish.constant.all.LIMMA 4.36e-59 5.60e-39 1.03e-03 ns ns ns
none.vsn.all.pmonly.medianpolish.quantiles.all.FoldChange 2.77e-32 ns ns ns ns ns
rma.vsn.all.pmonly.medianpolish.scaling.all.SAMR 6.22e-61 3.64e-44 4.05e-05 ns ns ns
ap-values for testing whether the relative AUC values corresponding to a specific number of arrays is less than 95% of the relative AUC value 
achieved by the same route in the Platinum Spike dataset.
bThe routes used for sample size study. They are modified from nine of the top 10 routes (excluding Alchemy) assessed in the Platinum Spike 
dataset by using all arrays for normalization.
cns: not significant, based on the multiple hypothesis correction using Holm's method.Zhu et al. BMC Bioinformatics 2010, 11:285
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choice of analysis route for their particular experiment.
Our data suggest that a single "best" route for all microar-
ray experiments may not exist.
Methods
cRNA sample preparation and hybridization
PCR products generated from 5725 Drosophila  Gene
Collection release 1.0 (DGCr1) cDNA clones were col-
lected into 28 distinct pools. PCR was conducted as
described, with clones that failed to amplify eliminated
from subsequent analysis; the number of mislabeled
clones was previously estimated to be less than 3% [5].
Biotin-labeled cRNAs were generated from each pool
using the Ambion MEGAscript kit with T7 or SP6 poly-
merase, as appropriate. Reactions were purified using
QIAGEN RNeasy columns and resulting concentrations
were measured by RiboGreen assay (Invitrogen). The
labeled cRNAs from each pool were mixed together with
specified relative abundance to generate samples repre-
senting the A and B conditions. Note that as all labeling
was performed per pool and pools only subsequently
added to the A and B samples, all cRNAs from the same
pool have identical fold change values between samples
(Figure 1A and Additional file 1, Figure S1; see also dis-
cussion in [25]). Three independent sample preparations
were performed for each condition. 24 clones from the
Drosophila Gene Collection release 2.0 (DGCr2) that did
not have sequence similarity with DGCr1 clones and
could be assigned to a unique Affymetrix probe set were
added to each sample in known concentrations before
hybridization (Additional file 3, Table S2). Eukaryotic
Hybridization Controls were added to the hybridization
cocktail and each sample was hybridized in triplicate to
GeneChip® Drosophila Genome 2.0 Array using standard
Affymetrix protocols. Roughly 3.9 μg cRNA was used for
each hybridization. The Platinum Spike dataset has been
deposited in GEO with series accession number
GSE21344.
Clone sequences and probe set assignment
Out of the 5749 cDNA clones in the samples, 5594 had
known full length clone sequences. Of the remainder, 154
clone sequences were inferred from the corresponding 5'
and/or 3' EST sequence (see Supplemental methods in
Additional file 2); one cDNA had no reliable clone
sequence and was therefore omitted from the analysis.
Based on the sequence alignment of all perfect match
(PM) probes on the Drosophila Genome 2.0 Array against
the obtained clone sequences (see below), we assigned
5597 probe sets to a total of 5339 clones whose cRNAs
were present in the samples. 18 probe sets were designed
for the cRNAs in Affymetrix Eukaryotic Hybridization
Controls and were considered to have fold change = 1
between conditions, as identical amounts of Affymetrix
Eukaryotic Hybridization Controls were added to each
array according to the Affymetrix protocol. The remain-
ing 13,337 probe sets did not map to any cRNAs in the
samples and are referred to as "empty" probe sets.
To identify the Affymetrix probe sets hybridized to the
cRNAs, we aligned the sequences of all PM probes to the
obtained sequences of the clones present in the cRNA
samples using BLAST [35] (version 2.2.18) with word size
seven, no complexity filter and e-value cutoff 1. In order
to call a PM probe matched to a clone, we required that
no fewer than 60% of the probe sequence matched identi-
cally to a clone sequence on the correct strand with no
gaps. If at least 15% of the probes in a probe set matched
to the same clone, we assigned the probe set to that par-
ticular clone. If there are always one-to-one matches
between probe sets and clones with full length cDNA
sequences, we expect 29.5% (5594/18952) of the probe
sets in the Drosophila Genome 2.0 Array to have a clone
assignment. The two cutoffs were chosen to achieve this
percentage value while maintaining the unique clone
assignments of most probe sets (95.9%). Using more
stringent cutoffs did not significantly influence probe set
assignment. For clones with multiple potential clone
sequences (see Supplemental methods in Additional file
2), if a probe set mapped to no fewer than 90% of the mul-
tiple potential sequences of the same clone, the probe set
was assigned to that particular clone (Additional file 4).
There were 231 probe sets assigned to multiple clones
and 14 probe sets assigned to clones present in multiple
pools. These probe sets were excluded from the evalua-
tion of DEG detection, but still considered as "not empty"
in assessment of present/absent calls (Additional file 5).
Present/absent call
The MAS 5.0 detection algorithm was performed by
using the mas5calls function from the Bioconductor affy
library [36] with τ = 0. The choice of value for τ in the
Wilcoxon signed rank test can affect the outcome of the
detection algorithm. In theory , when the true target is
absent and both PM and MM probes are detecting only
non-specific signals the discrimination score (PM-MM)/
(PM+MM) will approach zero, suggesting an idealized τ
value equal to zero. The MAS 5.0 detection algorithm
defaults to a small τ value above zero, 0.015. We found
that the results are consistent using either τ value, and
only the results corresponding to τ = 0 are reported here.
The returned p-values from the Wilcoxon signed rank
test were used to generate ROC curves and calculate the
AUC value of each array using the ROCR library [37].
Background correction
The background correction step was either skipped
(none) or performed using one of three popular back-
ground correction algorithms: gcrma  (version 2.14.1),
MAS 5.0 (mas), and RMA (rma). As gcrma can be usedZhu et al. BMC Bioinformatics 2010, 11:285
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with different parameters, we tested all possible gcrma
settings: gcrma-rml (using reference probe affinity infor-
mation and maximum likelihood estimation; the default
setting of gcrma), gcrma-reb (using reference probe affin-
ity information and empirical Bayes estimation), gcrma-
lml (using local probe affinity information and maximum
likelihood estimation), gcrma-leb (using local probe affin-
ity information and empirical Bayes estimation). Using
maximum likelihood estimation is achieved by setting
"fast = TRUE" in the gcrma function, while using empiri-
cal Bayes estimation is achieved by setting "fast = FALSE".
We also applied the modified gcrma background correc-
tion used by Schuster et al. (gcrma-sch) [7], which is in a
similar setting as gcrma-leb  but without adjusting the
probe effects in specific binding. By default, gcrma and
rma only correct PM probe intensities. As the MAS 5.0
detection algorithm requires both PM and MM probe
intensities,  gcrma  and  rma  were modified to correct
background for both PM and MM probes.
Probe normalization methods and normalization groups
The PM and MM probe intensities after the background
correction step were either not normalized (none) or nor-
malized with one of the six normalization methods: con-
stant, scaling, invariantset [38], loess [39], quantiles [39],
and  vsn  [40]. Normalizations were either carried out
among technical replicates (technical  group), among
arrays under the same condition (conditional), or among
all 18 arrays (all, Figure 1B).
DEG detection
Background correction and probe normalization
The same methods evaluated for present/absent call were
used in these two steps except that gcrma-sch was not
used, and for routes using gcrma or rma as background
correction, only PM probe intensities were adjusted in
these two steps.
PM correction
Each probe pair contains one PM probe and one MM
probe. We either directly used PM probe intensities
(pmonly) as the corresponding probe pair intensities, or
calculated the probe pair intensities based on the method
used by MAS 5.0 (mas). As gcrma and rma only adjust
PM probe intensities at the background correction step,
mas PM correction is not compatible with these back-
ground correction methods.
Summarization
The summarization step is employed to estimate the
intensity of each probe set based on multiple probe pairs.
We tested four different summarization methods: medi-
anpolish  [17], Tukey-biweight (mas) [16], FARMS  [11],
and DFW [9].
Probe set normalization
We either skipped probe set normalization (none) or used
one of the five normalization methods: constant, scaling,
loess, quantiles, or vsn. The different normalization meth-
ods were coupled with each of the three normalization
groups.
DEG tests
Four methods were used for prediction of DEGs based on
summarized probe set intensities: fold change (simply cal-
culating log2 fold change between the A and B condi-
tions), CyberT  [41], LIMMA [42] and the R version of
SAM (SAMR) [43].
Combined methods
Several of the tested methods are integrated algorithms
that cannot be separated into individual steps as above.
For example, multi-mgMOS (mmgmos) [44] estimates
expression levels of probe sets using a Gamma distribu-
tion to model probe pair intensities across multiple
arrays. As the method uses both PM and MM intensities
at the same time, there is no PM correction step for this
method. gcrma and rma only correct PM intensities and
therefore are not compatible with mmgmos. Given raw
probe intensities, the PerfectMatch program [45] calcu-
lates gene expression levels based on the position-depen-
dent-nearest-neighbor (PDNN) model, which is a binding
free energy model of the cRNA and DNA probe duplex.
We also evaluated the performance of DEG detection
using probe set intensities obtained directly from the
gcrma, rma, and mas5 functions in R with default set-
tings. The GoldenSpike  [5] and Alchemy  [8] packages
detect DEGs by combining the results from the top 10
routes evaluated on the Golden Spike dataset. Two routes
used in Alchemy utilize the PerfectMatch results. We also
tried a variant of Alchemy, which only uses the eight
routes that do not depend on PerfectMatch results; we
refer to this approach as Alchemy2.
ROC curves
For routes using fold change to detect DEGs, the absolute
values of log2 fold change were given to the ROCR library
to generate the ROC curves and calculate the AUC val-
ues. For routes using CyberT, LIMMA or SAMR, the AUC
values were calculated based on the absolute values of the
corresponding test statistics. The absolute values of the
composite statistics from the GoldenSpike  package,
Alchemy and Alchemy2 were used to calculate the corre-
sponding AUC values.
False discovery rate
The permutation-based q-values of the overall top 10
routes were calculated from 1500 permutations using the
algorithm implemented in the GoldenSpike package. The
q-values based on Benjamini and Hochberg's method
(BH) were calculated by using the p.adjust function in R.
As this function requires p-values as input, we were not
able to calculate the BH-based q-values for the routes that
did not report p-values. The actual q-values wereZhu et al. BMC Bioinformatics 2010, 11:285
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reported from the ROCR library by using the calculated
q-values to rank the probe sets.
Computation
All computations were performed on the operating sys-
tem RedHat Enterprise Linux 4, 2.6 Kernel. R version
2.7.2 [46] and Bioconductor version 2.2 were used in this
study.
Additional material
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DEGs: differentially expressed genes; PM: perfect match; AUC: area under the
curve; TPR: true positive rate; FPR: false positive rate; FDR: false discovery rate.
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